US-based drug discovery and development firm, Heptares Therapeutics has delivered the first stabilised G protein-coupled receptor (GPCR) called 'StaR' to MorphoSys for antibody discovery as part of their antibody therapeutics alliance. ...
Tags: Heptares Therapeutics, drug
MorphoSys and Heptares Therapeutics have signed a research deal to develop antibody therapeutics against G protein-coupled receptors (GPCRs). According to the deal, Heptares will produce stabilized receptors (StaRs) for MorphoSys proposed ...
Tags: antibody therapeutics, Heptares Therapeutics, GPCR disease